correcaminos
Well-Known Member
From my understanding after considering the Pfizer/BioNTech trial for my teen, was that the teens are getting the same dosage as adults. The children will be different doses as well. So they need to see reactions of slightly smaller people - though to be fair at 12, mine was already bigger than me lol - and go from there. As it is, it was harder for them to get teens for the trial. I'll post more below the next comment as to why.Pfizer’s 12-15 has been fully-enrolled for weeks. Moderna’s 12-17 is fully-enrolled as of today.
And yet, still no start date for younger kids other than “soon”. I understand it takes awhile. Why haven’t they started, then? If case numbers continue to fall, it will be even harder to get volunteers (once the virus “isn’t dangerous”) and will take longer to collect data due to a lower infection rate once it is summer (the virus shows seasonality) and school is out.
Ours is about 30-45 minutes away as long as traffic isn't awful and even that adds up for us. The trials are time consuming. My first appointment was 3 hours in when a computer glitch sent me home. My second visit I had to start all over again and it took 4 hours not including time to get there and back. Third visit was 2.5 hours or so. Forth visit was maybe 45 minutes (only a blood draw). Add in travel time and for us, crazy school changes from hybrid to distance learning to hybrid etc and I couldn't figure out how to do it with my son. If in hybrid he'd miss his only in person time with the teachers for a week. They were not, at the time, doing weekend or night hours either. Add in a hint of fear of needles and we opted not to enroll my about to turn 13yo.The closest juvenile trial is almost a 2hr drive from me. Missing work for a trial combined with a kid missing school due to the appointments, there's no way I would travel that far even if mine qualified.
Total truth as sad as it is!I think in the grand scheme of modern medical costs...none are that pricey. Drop in the bucket all things considered.